MLEC - Moolec Science SA


0.664
0.070   10.587%

Share volume: 20,650
Last Updated: 04-08-2025
Trading/Investment Offices: 0.12%

PREVIOUS CLOSE
CHG
CHG%

$0.59
0.07
0.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
5.87%
1 Month
-21.42%
3 Months
-25.38%
6 Months
-18.02%
1 Year
-45.57%
2 Year
-84.45%
Key data
Stock price
$0.66
P/E Ratio 
0.00
DAY RANGE
$0.61 - $0.66
EPS 
N/A
52 WEEK RANGE
$0.53 - $2.17
52 WEEK CHANGE
-$45.06
MARKET CAP 
32.684 M
YIELD 
N/A
SHARES OUTSTANDING 
37.564 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
-0.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$13,234
AVERAGE 30 VOLUME 
$20,795
Company detail
CEO: Gastón Paladini
Region: US
Website: moolecscience.com
Employees: 4
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry: Trading/Investment Offices
Sector: Finance, Insurance, And Real Estate

Moolec Science is a science-based ingredient company focused on producing animal proteins in plants through Molecular Farming. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybeans and peas.

Recent news
loading